☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Rectogesic rejected by SMC

The Scottish Medicines Consortium has rejected Glyceryl Trinitrate 0.4% Ointment (Rectogesic) for use in Scotland.

The advice issued by the Consortium agrees that this product lowers pain scores more than a placebo ointment but they felt the effect was small and that an economic case for use was not demonstrated. This economic case was made based up healing rates compared to surgery, but rectogesic is not licensed to heal anal fissures.

Action: Symptomatic treatment of anal fissures at presentation should be based on lifestyle advice about diet and bowel habit. Prescriptions for products containing topical steroids or anaesthetics may be appropriate for management of pain and inflammation.

Share 'Rectogesic rejected by SMC' by emailShare 'Rectogesic rejected by SMC' on FacebookShare 'Rectogesic rejected by SMC' on TwitterShare 'Rectogesic rejected by SMC' on LinkedInShare 'Rectogesic rejected by SMC' on reddit


One Comment to “Rectogesic rejected by SMC”

  1. […] This latest advice is based upon a resubmission of data after the SMC had rejected the product last year as reported here. […]

    Pingback by SMC reject Rectogesic | Prescribing Advice for GPs — April 11, 2006 #

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.